1. USD

    71.42

    Today's change

    -1.65 / -2.26%

    1 year change

    +2.10%

    As of Feb 11 2016 21:03 GMT. Data delayed by at least 15 minutes.

Search for Eli Lilly & Co and
  1. Fast FT

    January 28, 2016

    Healthcare, biotech stocks slammed

    It’s another brutal day for healthcare and biotech stocks, which have been prone to big sell-offs ever since Hillary...

  2. January 25, 2016

    Brexit would be a ‘mistake’, say global pharma leaders

    A British exit from the EU would isolate the country’s scientists and reduce its influence in medicine, global...

Special Reports

  1. Combating Diabetes

    Urbanisation, poor diet and failure to exercise have led to record levels of obesity, ...
  2. Special Report: Boldness in Business 2012

    Seven success stories are honoured in this year’s awards...
Search more Special Reports on this topic.

  1. January 18, 2016

    Pharma sell-off threatens to stifle appetite for IPOs

    After months of battling a public outcry over high drug prices, the pharmaceuticals and biotech industry had hoped that...

  2. Fast FT

    January 5, 2016

    Eli Lilly shares dip pre-market after fresh forecasts

    Eli Lilly, the US drugmaker that has steered clear of the frenzy of dealmaking sweeping the pharmaceutical industry,...

  3. December 30, 2015

    China Animal Healthcare document loss highlights investor risks

    In the litany of accounting problems emerging at Chinese companies, Hong Kong-listed China Animal Healthcare has...

  4. December 15, 2015

    Sanofi/Boehringer: swap shop

    Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

  5. December 15, 2015

    Sanofi seeks to expand in consumer health with €18bn asset swap

    Sanofi has entered exclusive talks with Boehringer Ingelheim over an €18bn asset exchange that would see the French...

  6. December 1, 2015

    Eli Lilly and Merck bolstered by upgrades

    Pharmaceutical stocks received a shot in the arm after analysts at Barclays upgraded Eli Lilly and Merck citing...

  7. November 13, 2015

    Animal health: double or quits

    Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

  8. October 21, 2015

    Pharma groups join UK in $100m dementia fund

    A $100m dementia research fund has been launched with backing from the British government and several of the world’s...

  9. October 18, 2015

    Weekahead: Corporate diary

    Diary commentary from FT reporters; data and company announcements, unless otherwise stated, from Thomson Reuters....

  10. October 12, 2015

    Eli Lilly’s heart-drug setback reverberates through pharma sector

    Shares of several of the US’s largest drugmakers were roiled on Monday after Eli Lilly surprisingly halted development...

  11. October 12, 2015

    Eli Lilly shares sink as it scraps heart drug

    Eli Lilly has pulled the plug on a potential blockbuster medicine intended to ward off heart attacks and strokes,...

  12. October 6, 2015

    Axovant seeks first approval for an Alzheimer’s drug in a decade

    A company that completed the largest ever biotech listing earlier this year has started testing its Alzheimer’s...

  13. October 6, 2015

    Bristol-Myers to pay SEC $14m to settle China bribery claim

    US drugmaker Bristol-Myers Squibb is to pay $14m in penalties to US authorities over alleged “improper payments” made...

  14. September 24, 2015

    Eli Lilly set for diabetes drug boost

    When Eli Lilly and Boehringer Ingelheim unveiled the results of a study into Jardiance, their diabetes drug, at a...

  15. July 24, 2015

    Week in Review, July 25

    A round up of some of the week’s most significant corporate events and news stories. Credit Suisse soars on back of...

  16. July 22, 2015

    Eli Lilly: think it through

    The search for a cure for the degenerative disease Alzheimer’s has been long and hard. Billions have been spent....

  17. July 22, 2015

    Alzheimer’s breakthrough hopes add to promise of pharma revival

    Hopes of a breakthrough against Alzheimer’s disease have been boosted by encouraging clinical trial data from Eli Lilly...

  18. July 22, 2015

    Eli Lilly raises hopes for breakthrough Alzheimer’s drug

    Eli Lilly has raised hopes for a breakthrough in the treatment of Alzheimer’s disease after unveiling evidence that its...

  19. July 19, 2015

    Pharmaceuticals: Brain power

    Garbed in white lab coat and goggles, a young scientist carefully cuts a mouse’s brain into wafer thin slices. She adds...

  20. July 17, 2015

    Cautionary tale as Receptos benefits from buying frenzy

    If you can’t beat ’em, buy ’em. That seems to be the mantra this week after Celgene agreed to pay $7.2bn for the maker...

  21. July 16, 2015

    Immunocore in record European biotech raising

    Immunocore, the Oxford-based cancer drug developer, has secured $320m in the biggest private fundraising by a European...

  22. July 1, 2015

    Pharma groups eye healthy returns from animal drugs market

    A treatment for dogs with itchy skin has turned out to be something of a tonic for investors. Apoquel launched last...

  23. June 29, 2015

    Eli Lilly and Immunocore in cocktail collaboration against cancer

    Eli Lilly of the US is to expand its alliance with Immunocore of the UK in the latest example of pharmaceuticals...

  24. June 25, 2015

    Johnson floats £10bn biotech fund for London

    Plans for a £10bn fund to boost investment in life sciences have been floated by Boris Johnson, London mayor, as part...

  25. April 29, 2015

    Takeda to pay $2.7bn to settle Actos cancer claims

    In one of the largest product liability settlements to date, Takeda Pharmaceutical has agreed to pay $2.7bn over claims...

  26. April 5, 2015

    UK reprieve for three cancer drugs

    Three cancer drugs that were supposed to be removed from the National Health Service on cost grounds have been granted...

  27. March 27, 2015

    Insulin: moving the needle

    It has been a sweet run. The biggest companies in the insulin business — Sanofi, Novo Nordisk, and Eli Lilly — have...

  28. March 26, 2015

    Indiana signs ‘religious freedom’ bill

    Indiana Governor Mike Pence has signed a bill that would allow businesses to refuse service to gay and lesbian patrons...

  29. March 20, 2015

    Biogen’s Alzheimer’s drug shows early promise

    An experimental Alzheimer’s drug being developed by a US biotech group has offered hope that scientists may be closer...

  30. March 17, 2015

    Dementia research boosted by $100m venture capital fund

    Research into dementia is to be boosted by a $100m venture capital fund backed by the UK government and several of the...

  31. February 24, 2015

    Eli Lilly stays out of deals fray as it eyes ‘moon shot’ drugs

    The pharmaceutical industry is gripped by deals fever, but one company is conspicuously absent from the lists of...

  32. February 2, 2015

    Big pharmaceuticals groups faces biosimilars challenge

    Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

  33. December 11, 2014

    Broker’s upgrade boosts Eli Lilly shares

    Eli Lilly shares were buoyed by a brokerage upgrade on Thursday as Morgan Stanley analysts gained confidence over the...

  34. November 13, 2014

    Spread of city life destroys myth of diabetes as a western illness

    Which country has the most diabetics? The US seems the obvious candidate given its high rate of obesity – the main...

  35. November 13, 2014

    Diabetes researchers find hope in link with dementia

    From his office at the Hammersmith Hospital in west London, Dr Paul Edison has begun the search for patients to...

  36. September 16, 2014

    AstraZeneca swallows bittersweet pill with Eli Lilly Alzheimer’s deal

    Consciousness, the lens through which humans perceive the world, is ill-adapted for perceiving itself. The paradox is...

  37. September 16, 2014

    AstraZeneca and Eli Lilly to unite for Alzheimer’s drug challenge

    AstraZeneca has struck a deal to jointly develop a treatment for Alzheimer’s disease with Eli Lilly of the US in a...

  38. September 15, 2014

    Lessons in failure from the error management gurus

    How do, and how should, businesses handle failure? Employers often talk about empowering people to take risks and learn...

Search for Eli Lilly & Co and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on whether 26% share climb is overly optimistic...
    July 22, 2015

    Lex on whether 26% share climb is overly optimistic

  2. Eli Lilly's John Lechleiter says pharma must reach out to inn...
    June 15, 2012

    Eli Lilly's John Lechleiter says pharma must reach out ...